Dr Donald Coppen joins Algeta
This article was originally published in Scrip
The Norwegian company Algeta has named Donald Coppen business development director. Dr Coppen joins from Biocompatibles International (now part of BTG), a UK-based oncology company, where he was director, partnering and licensing. He previously held project leadership and managerial roles at Lonza Biologics in the UK, and within the crop protection division of Cyanamid International, part of Wyeth (now Pfizer), in Belgium.